Pulmonary Drug Delivery
Issue No #62
December 1st, 2015
Inside the magazine
: A NEW pMDI METERING VALVE PLATFORM THAT PATIENTS CAN COUNT ON
Inga Meyer introduces the company’s new pressurised metered-dose inhaler (pMDI) valve platform, Inhalia, and uses device testing study data to demonstrate some of the significant advances, advantages and benefits the platform brings.
HUMAN-CENTRED DESIGN & INHALATION DEVICE DEVELOPMENT
Bill Welch explains how the term “smaller and smarter” applies in the development of inhalation devices, and describes how his company’s human-centred design approach.
PATIENT PREFERENCE IN RESPIRATORY DEVICE TRAINING & EDUCATIONAL TOOLS
Paul Sullivan and Craig Baker provide data from recent patient studies to emphasise the importance of training devices in improving adherence to, and compliance with, inhaled therapeutics.
WHY SUCCESS IN DRUG DELIVERY IS NOT JUST ABOUT THE DEVICE
Mark Tunkel explains how companies developing and marketing inhalable pharmaceuticals can explore other strategies to improve patient outcomes over and above what the drug and device can achieve.
Dr David Lewis
REVIEWING CURRENT THINKING ON THE
BEHAVIOUR OF PARTICLES IN THE EXTRA-FINE REGION
David Lewis reports the latest research on the changing view of the behaviour of particles in the extra-fine region and their potential for enhancing inhaled drug therapies.
IMPROVING DRUG STABILITY & DRUG DELIVERY BY MODIFICATION OF MDI CANISTER SURFACES
Richard Turner explains how, in recent years, a number of surface coatings have been developed that can be applied to MDIs canisters and valve components, to protect the contents from deposition and degradation.
A NEW, ADVANCED HIGH-THROUGHPUT SYSTEM FOR AUTOMATED INHALER TESTING
Adam Smith introduces DecaVertus, describing its single inhaler predecessor the Vertus, and how the DecaVertus design evolved using the Vertus technology.
This website uses functional cookies (but not advertising cookies). View our
Privacy & Cookies Policy